Connect with us

CBD

Global Cannabidiol (CBD) Market 2020 Leading Strategies and Growth Status to 2025 – Kazmira, ENDOCA, CW Hemp/CW Botanicals, Green Road, Medical Marijuana – KSU

Published

on

Global Cannabidiol (CBD) Market Growth 2020-2025 presents a careful study of the current market scenario that includes extensive industry intelligence. The report highlights specific references and the strategic functionality of various global market elements. The report examines practical growth strategies and recommendations related to the global cannabidiol (CBD) industry. It also includes helpful and important facts and figures, expert opinions, and the latest developments around the world. When calculating the global market size, the report takes into account the revenue from sales of cannabidiol (CBD) around the world.

The report helps readers assess future-specific growth probabilities, as well as a thorough assessment of the primary growth initiators and focused elements that increase growth income generation and align with appropriate growth goals. Exclusive and relevant factors related to this market are highlighted. The key players in global and key regions are assessed and the market classified based on product and application / end industries. The report sheds light on several sections of the report including the global Cannabidiol (CBD) Market Size and Forecast, Drivers, Challenges, Trends, and more.

NOTE: In addition to public health, COVID-19 also has a significant impact on the global economy. This particular pandemic had caused severe economic devastation and not a single country was left untouched. The virus has forced companies around the world to change the way they work. This report provides an analysis of the COVID-19 consequences in the Cannabidiol (CBD) Market.

DOWNLOAD FREE SAMPLE REPORT: https://www.marketsandresearch.biz/sample-request/139087

This comprehensive report analyzes the competitive landscape in terms of markets, applications, and regions. Competitive analysis helps providers to know their capabilities and opportunities for future growth prospects. The report then provides an in-depth assessment of market participation presented by curious market participants followed by an assessment of their general standing in the competitive landscape. The global size of the cannabidiol (CBD) industry is defined and forecast in terms of type, application, and region.

The top players listed in the market report are:

Kazmira, ENDOCA, CW Hemp / CW Botanicals, Green Road, Medical Marijuana, Freedom Leaf, Cannavest, Folium Biosciences, Pharmahemp, HempLife Today, Aphria, Whistler, Emblem Cannabis Oils, CBD American Shaman, KIND Concentrates, Select Oil, Absolute Terps, Canopy Growth Corporation, NuLeaf Naturals, The Lab

Depending on the type, the report was divided into:

Hemp-derived type, marijuana-derived type

Based on the application market is divided into:

Pharmaceutical industry, food industry, cosmetics industry, others

Market segmentation by region:

America (USA, Canada, Mexico, Brazil), APAC (China, Japan, Korea, Southeast Asia, India, Australia), Europe (Germany, France, Great Britain, Italy, Russia), Middle East and Africa (Egypt, South Africa), Israel , Turkey, GCC countries)

Key numbers measured in this report:

The report includes the financial implications of various developments that include production and consumption patterns. Expert opinions also ensure that growth retardation is a major concern that is further believed to have suitable indications for the times to come. Additionally, the global cannabidiol (CBD) report highlights the vendors’ successive merger and acquisition strategies, geographic expansion, research and development, and new product launch strategies to help them further expand and grow the business.

FULL ACCESS REPORT: https://www.marketsandresearch.biz/report/139087/global-cannabidiol-cbd-market-growth-2020-2025

Highlights of the report:

  • The report explains the current market conditions in detail
  • The report highlights the leading companies in the global Cannabidiol (CBD) market covering technology interventions, production processes, business models, product offerings, pricing structure, and more.
  • The strategically relevant initiatives required in the market to maintain the competitive landscape for market participants are mentioned in the report.
  • The production and distribution structures and respective trading patterns in the global Cannabidiol (CBD) market are examined in the report.

Adaptation of the report:

This report can be customized according to the needs of the customer. Please contact our sales team (sales@marketsandresearch.biz) who will ensure you receive a report that meets your needs. You can also contact our executives at 1-201-465-4211 to share your research needs.

Contact us
Mark Stone
Head of business Development
Phone: +1 201-465-4211
E-mail: sales@marketsandresearch.biz
Network: www.marketsandresearch.biz

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published.

CBD

Financial Review: Real Brands (OTCMKTS:RLBD) & Vintage Wine Estates (NASDAQ:VWE)

Published

on

Real Brands (OTCMKTS:RLBD – Get Rating) and Vintage Wine Estates (NASDAQ:VWE – Get Rating) are both small-cap consumer discretionary companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, earnings, profitability, valuation and dividends.

Analyst Recommendations

This is a summary of current ratings and target prices for Real Brands and Vintage Wine Estates, as provided by MarketBeat.

sell ratings hold ratings Buy rating Strong Buy Ratings rating score
Real Brands 0 0 0 0 N / A
Vintage Wine Estates 0 0 3 0 3.00

Vintage Wine Estates has a consensus target price of 13.80, suggesting a potential upside of 74.24%. Given Vintage Wine Estates’ higher probable upside, analysts plainly believe Vintage Wine Estates is more favorable than Real Brands.

Earnings & Valuation

This table compares Real Brands and Vintage Wine Estates’ top-line revenue, earnings per share and valuation.

Gross revenue Price/sales ratio Net Income Earnings Per Share Price/earnings ratio
Real Brands $10,000.00 6,881.25 -$2.80million N / A N / A
Vintage Wine Estates $220.74 million 2.19 $9.87 million 0.06 132.02

Vintage Wine Estates has higher revenue and earnings than Real Brands.

profitability

This table compares Real Brands and Vintage Wine Estates’ net margins, return on equity and return on assets.

net margins return on equity return on assets
Real Brands N / A N / A N / A
Vintage Wine Estates 3.32% 5.05% 2.39%

Summary

Vintage Wine Estates beats Real Brands on 7 of the 8 factors compared between the two stocks.

About Real Brands (Get Rating)

Real Brands, Inc. engages in the extraction of hemp cannabinol (CBD) oil/isolate, wholesale of CBD oils and isolate, and production and sale of hemp-derived CBD consumer brands. The company offers tinctures, pet tinctures, disposable vape pens, pain gels, mint breath sprays, lavender moisturizers, clay face masks, foot creams, moisture recovery creams, hydra renewing night creams, and anti-aging concentrate serums. Its brands include American Standard Hemp, Ziggys Hemp Products, WA Brands, Phaze, Canni Clear Products, and Zen Pets Treats. The company is headquartered in North Providence, Rhode Island.

About Vintage Wine Estates (Get Rating)

Vintage Wine Estates, Inc. produces and sells wines and craft spirits in the United States, Canada, and internationally. The company offers its products under the Layer Cake, Firesteed, Bar Dog, Middle Sister, Cherry Pie, Cartlidge & Browne, GAZE Wine Cocktails, Girard, Clos Pegase, Laetitia Vineyard and Winery, Swanson Vineyards, Kunde Family Winery, Viansa, and BR Cohn Winery. It also owns and operates hospitality facilities; and provides bottling, fulfillment, and storage services to other companies on a contract basis. The company was founded in 2019 and is headquartered in Incline Village, Nevada.

Receive News & Ratings for Real Brands Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Real Brands and related companies with MarketBeat.com’s FREE daily email newsletter.

Continue Reading

CBD

Hyatt in Incline announces new treatment menu at Stillwater Spa

Published

on

INCLINE VILLAGE, Nev. – Hyatt Regency Lake Tahoe Resort, Spa and Casino, the only full-service waterfront resort in North Lake Tahoe, announces a new treatment menu at the award-winning Stillwater Spa & Salon. The new menu features customized treatment journeys that focus on the guest’s overall intention for their spa experience.

“We are thrilled to unveil a brand-new service menu at Stillwater Spa. The menu features holistic healing practices such as aromatherapy and Ayurveda paired with modern approaches for an elevated spa experience,” said Julie Orblych, director of spa and wellness at Hyatt Regency Lake Tahoe Resort, Spa and Casino. “My talented team and I have worked hard to create a menu of spa experiences designed to focus on wellness intentions. Rather than providing a list of traditional services, the menu matches guests with the services that best fit their overall wellness goals, whether that’s finding a sense of calm or balance from a massage, or seeing a glowing or hydrated result from a facial.”

Stillwater Spa’s updated service menu features five new massages guided by intention including “Balancing,” “Calm,” “Immunity,” “Renew,” “Love,” and “Unity.”

The “Balancing” massage uses Ayurveda dosha balancing techniques while utilizing warm herbal-infused oil. The “Calm” intention massage is designed to promote a sense of overall wellbeing with aromatherapy featuring lavender bergamot, clary sage, and chamomile to comfort and calm. The “Immunity” intention utilizes a relaxing massage that incorporates essential oils traditionally used to boost the immune system, and the “Renew” service is ideal for travel fatigue with refreshing and invigorating aromatherapy. Finally, the “Love” service inspires self-care and is designed to encourage a sense of joy, and “Unity” is a couples’ massage designed to enhance overall balance of the mind, body, and soul.

Each massage option can be enhanced with a deep tissue muscle renewal, or the application of CBD oil to help further relieve muscle pain or tension.

The new facial options include the “Indulgence” anti-aging facial that features a protein-rich caviar and powerful marine actives to firm and refine skin tone. The Ultimate Hydrafacial treatment includes lymphatic drainage, LED light therapy, and a hydrating algae gel mask.

The “Rejuvenate” facial option uses Intraceuticals Oxygen to naturally cool and calm the skin followed by the application of concentrated serums, and the “Glow” option features a super charge of Vitamin C combined with an AlphaBeta® Professional Peel System.

Guests can also select from two signature experiences. The “Peace” signature experience includes a stress relieving neck, shoulder, scalp and focused foot massage while wrapped in warm linens steep in an herbal detox infusion. The “Harmony” signature experience incorporates the use of a bioacoustics mat, which delivers low frequency sound pulsations designed to provide a deep acoustic massage for joint and tissue relaxation.

Additionally, Stillwater Spa offers a selection of updated body treatments. The services include the “Refresh” body treatment consisting of a full body exfoliation followed by a hydrating moisturizer; the “Relief” body treatment which includes a powerful blend of water-soluble broad-spectrum CBD, and flotation therapy sessions utilizing “Pearl,” the resort’s spacious float orb.

For more information, visit HyattRegencyLakeTahoe.com, or call 775-886-6745.

Continue Reading

CBD

Taking CBD with herbal supplements could cause severe heart symptoms

Published

on

Share on PinterestCombining different herbal supplements could lead to severe cardiac problems, a case study suggests. MEHAU KULYK/SCIENCE PHOTO LIBRARY/Getty Images

  • Using herbal supplements, including derivatives of cannabis, is becoming more and more popular.
  • Some supplements are easy to get over the counter and are not as highly regulated as other medications.
  • A recent case study demonstrates that using certain supplements in excess can lead to severe heart problems.

People’s use of supplements has increased in recent years. Many supplements may carry a certain amount of health benefits, but as they are not regulated, people should also exercise caution.

A recent case report published in Heart Rhythm Case Reports demonstrates that the excessive use of certain substances such as hemp oil could lead to severe cardiac problems.

Supplements are readily available to consumers and can offer various health benefits. For example, dietary supplements provide more of the substances found in food, such as specific vitamins or minerals.

Unlike medications, the Food and Drug Administration (FDA) does not offer as much regulation for dietary supplements.

dr Edo Paz, cardiologist and vice president of Medical at K Health, who was not involved in the study, explained the issue with supplements to Medical News Today:

Because the FDA regulates supplements differently than medications, the supplements are not well-studied, so the precise characteristics and side effects are not well known. You may even see variations in the preparation based on the distributor and batch.”

dr Paz said he encourages his patients to avoid supplements, out of a lack of solid data.

“If they do plan to use them, I do my best to research the possible side effects and drug-supplement interactions, but this is not always possible given the lack of data,” he added.

A few examples of common supplements include calcium, vitamin D, garlic, and ginkgo. Sometimes, supplements are a combination of many compounds, such as the supplement berberine, which may be helpful in the improvement of heart problems and gut health.

The CBD market

One group of supplements that have become quite popular are those derived from cannabis. A few examples of cannabis derivatives include hemp oil and cannabidiol (CBD).

Hemp oil has many potential benefits, including helping reduce muscle tension and stress and pain relief. Similarly, CBD may help with pain relief and may even help to reduce anxiety.

Currently, the FDA has only approved one derivative of CBD oil for medicinal use, Epidiolex, which can be used to treat seizures. Different derivatives of cannabis are still available as supplements, meaning that people can buy and use them without supervision from a medical professional.

The case report in question examined one 56-year-old woman and her severe symptoms that coincided with supplement use. She experienced episodes of syncope (fainting) and dizziness.

Upon cardiac evaluation, medical professionals discovered that she had low blood pressure and an abnormal heart rhythm called Torsade de Pointes. This particular disturbance in heart rhythm can become life threatening.

She also experienced a prolonged QTc, which indicates problems with the heart’s electrical signals. Prolonged QTc is often associated with Torsade de Pointes.

Her magnesium levels were also low, and after treatment with intravenous magnesium and saline fluids, her heart rhythm stabilized. Her personal medical history was unremarkable. But she revealed that she had been taking hemp oil that contained both CBD and cannabigerol (CBG).

She claimed to be taking it for stress-related reasons and was taking it at six times the recommended dose. She was also taking supplements containing berberine.

Doctors discontinued all of her supplement use while she was in the hospital. After five days, her heart rhythm returned to normal.

Based on data from this patient and their study of data surrounding these supplements, study authors think that these supplements caused the patient’s QTc prolongation.

dr Paz noted that the case showed “a frightening side effect of herbal supplements.”

“In this case, the patient used various supplements, which resulted in a cardiac electrical abnormality called QT prolongation. The patient even developed a feared and potentially deadly consequence of QT prolongation called torsades de pointe, which can degenerate to sudden cardiac death,” he told MNT.

dr Paz said that thanks to the clinical team the cause of these effects was identified, and the electrical abnormality resolved after the patient stopped taking them.

This particular case study examined supplement use in one individual and the potentially severe cardiac problems that may follow. However, it is essential to note that she took an exceptionally high amount of hemp oil.

The patient was also taking more than one supplement, so her heart problems likely cannot be strictly attributed to one of them.

Pharmacology expert Professor Gary Stephens from the University of Reading, who was also not involved in the study, noted to MNT that more clinical trials regarding the use of these supplements were needed because of the limited data.

We need to perform controlled clinical trials with properly defined medicines of standardized composition,” he said.

However, Prof. Stephens also pointed out that he was not aware of any adverse cardiovascular effects ascribed to CBD in clinical trials.

“I’m unfamiliar with berberine, but the authors point out themselves that it has been reported to cause the cardiac side effect in the title of the paper,” he added.

dr Stephen Alexander with the University of Nottingham, and a cannabis expert who was not involved in the study, said people should use supplements cautiously.

“I would not expect the use of CBD or hemp oil to have a widespread negative impact on cardiovascular health, but it does underline the need to respect these agents and to treat them seriously (rather than to exceed recommended doses or combine with other poorly characterized supplements),” he told MNT.

He said the study highlighted the need for greater awareness and education about the use of supplements, in particular those derived from cannabis.

Disclaimer: Professor Gary Stephens has done some consultancy work for Jazz Pharmaceuticals. Jazz Pharmaceuticals also bought out the company GW Pharmaceuticals, the company behind the multiple sclerosis treatment nabiximols, which was the first cannabis-based medication licensed in the UK Prof. Stephens has also received funding from GW Pharmaceuticals. dr Stephen Alexander has been recruited to the Scientific Advisory Board of Jazz Pharmaceuticals.

Continue Reading
Advertisement

Trending